From Our Readers

From Our Readers

The Superwarfarin Chronicles

Over the past decade, the use of synthetic cannabinoids/marijuana has increased. These products generally consist of plant material sprayed with chemicals that can interact...
You Make the Call

How would you reduce the transfusion burden in a patient with CCUS?

Here’s how readers responded to a You Make the Call question about reducing the transfusion burden in a patient with clonal cytopenias of undetermined...
You Make the Call

How would you manage bleeding risk in a patient undergoing spinal surgery?

Here’s how readers responded to a You Make the Call question about bleeding prevention in a patient undergoing cervical spine surgery. Disclaimer: ASH does not...

The Problems With Paperless

In our April issue, we looked at the U.S. health-care system’s transformation from a paper-based system to electronic health records (EHRs), and clinicians’ love-hate relationship with the...

Workplace Violence

In our March 2018 issue, ASH Clinical News Associate Editor Alice Ma, MD, recounted an unnerving experience with a threatening patient in “Not What...
You Make the Call

How would you manage a patient who meets morphologic, but not molecular, criteria for...

Here’s how readers responded to a You Make the Call question about a patient with a morphologic presentation suggestive of acute promyelocytic leukemia (APL),...
You Make the Call

How would you treat a patient with the C282Y mutation and a family history...

Here’s how readers responded to a You Make the Call question about managing a patient with the C282Y mutation and a family history of...
You Make the Call

What are the treatment options for a pregnant woman with chronic-phase CML?

Here’s how readers responded to a You Make the Call question about managing a pregnant patient with chronic-phase (CP) chronic myeloid leukemia (CML). Disclaimer: ASH does...
You Make the Call

How would you manage VTE risk in a transgender patient who needs hormone replacement...

Here’s how readers responded to a You Make the Call question about venous thromboembolism (VTE) risk in a transgender patient who needs hormone replacement...

Doing No Harm Versus the Right to Bear Arms

In our December 2017 issue, “Gun Violence: A Public Health Crisis,” we spoke with experts about the complexities of treating gun control as a...
Advertisement

Current Issue

June 2019, Volume 5, Issue 7

This issue features a debate about new treatment options for beta-thalassemia, a look at what’s driving skyrocketing drug prices in myeloma, and more.